Shikonin and its derivatives inhibit the epidermal growth factor receptor signaling and synergistically kill glioblastoma cells in combination with erlotinib
2015 ◽
Vol 137
(6)
◽
pp. 1446-1456
◽
2012 ◽
Vol 12
(1)
◽
pp. 1381-1386
◽
2006 ◽
Vol 291
(2)
◽
pp. 278-290
◽
2012 ◽
Vol 350
(2)
◽
pp. 235-241
◽
2010 ◽
Vol 8
(5)
◽
pp. 783-797
◽
1997 ◽
Vol 272
(13)
◽
pp. 8121-8124
◽